CellR4 2021; 9: e3229
DOI: 10.32113/cellr4_20217_3229

Stem cell therapy for the treatment of musculoskeletal diseases: safe and effective or costly and temporary?

Topic: Stem cell therapy, Stem cells   Category:

Abstract

This opinion paper reviews the use of expanded bone marrow mesenchymal stem cells (MSCs) in the treatment of musculoskeletal diseases, especially osteoarthritis and traumatic joint damage. This paper assesses past and present stem cell-based technologies, possible concerns about safety and efficacy, alternative or possibly parallel therapies using platelet rich plasma (PRP) and exosomes, as well as the latest concepts in modulated laser activation of stem cells. The clinical trial status and medical literature on this subject are considered, and the latest Good Manufacturing Practice (GMP) bioreactor technology is proposed as the gold standard for MSC expansion.

To cite this article

Stem cell therapy for the treatment of musculoskeletal diseases: safe and effective or costly and temporary?

CellR4 2021; 9: e3229
DOI: 10.32113/cellr4_20217_3229

Publication History

Submission date: 04 Jun 2021

Revised on: 21 Jun 2021

Accepted on: 14 Jul 2021

Published online: 19 Jul 2021